Login

Healthcare

00:00:00
Oncimmune's strategic pivot aims for robust growth in 2024 - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:00:00
ONCIMMUNE HOLDINGS PLC - Investor Presentation - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:00:00
Oncimmune "relaunch" already delivering results - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:00:00
ONCIMMUNE HOLDINGS PLC - Strategy Update - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:00:00
Onconova Therapeutics featured on Worldwide Business - Dr. Steven Fruchtman, CEO, Onconova Therapeutics Inc
00:00:00
OptiBiotix Health delighted to launch range in India through Apollo - Stephen Patrick O'Hara CEO / Founder, OptiBiotix Health
00:00:00
OptiBiotix secures exclusive manufacturing agreement for CE marked SlimBiome - Stephen Patrick O'Hara CEO / Founder, OptiBiotix Health
00:00:00
Pharmaxis Ltd expects review of Bronchitol NDA to be completed by mid-2020 - Gary J Phillips B Pharm MBA - Chief Executive Officer, Pharmaxis Ltd
00:00:00
Pharmaxis welcomes positive interim data for Phase 2 cancer trial - Gary J Phillips B Pharm MBA - Chief Executive Officer, Pharmaxis Ltd
00:00:00
Pharmaxis extends scarring collaboration after encouraging results - Gary J Phillips B Pharm MBA - Chief Executive Officer, Pharmaxis Ltd
00:00:00
Orthocell raising $3.5 million; adds heavy hitters to register - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:00:00
Orthocell on the cusp of significant growth - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:00:00
Orthocell signs defining licence and distribution agreement - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:00:00
Orthocell talks appointment of exclusive Australian distributor for Remplir - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:00:00
Orthocell's CEO, Paul Anderson & Ticker News Interview - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd
00:00:00
Orthocell delivers outstanding results in Remplir nerve regeneration trial - Mr Paul Anderson Chief Executive Officer and Managing Director, Orthocell Ltd

© 2017 - Townhall + Tv